News | December 22, 2023
JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
His most recent stint was with Danone India as its Managing Director
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Decision on EU marketing authorisation expected for momelotinib by early 2024
Subscribe To Our Newsletter & Stay Updated
